市場調査レポート
商品コード
1380392
頭蓋穿孔器の世界市場:2023-2030年Global Cranial Perforators Market 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
頭蓋穿孔器の世界市場:2023-2030年 |
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 160 Pages
納期: 2~3営業日
|
頭蓋穿孔器の世界市場は予測期間(2023-2030年)にCAGR 7.8%で成長すると予測されています。脳腫瘍、外傷性脳損傷、脳内出血などの神経疾患の有病率の上昇により、頭蓋手術の需要は着実に増加しており、頭蓋穿孔器の需要が急増すると予測されています。世界保健機関(WHO)によると、約5,000万人がてんかんを患っており、世界的に最も一般的な神経疾患の1つとなっています。
製品別では、病院サブセグメントが頭蓋穿孔器の世界市場でかなりのシェアを占めると予想されます。病院セグメントは2022年に60.4%の最大市場シェアを占めました。これは、神経疾患患者の入院が増加しているためです。米国立生物工学情報センター(NCBI)によると、毎年2,260万人が神経学的損傷や障害に苦しんでおり、そのうち1,380万人が治療のために手術を必要としています。従って、神経学的入院患者数の増加が手術に必要な機器の需要を押し上げ、それによってこの分野の成長を牽引しています。技術的に先進的な頭蓋穿孔器が入手可能であり、有利な償還政策と相まって、予測期間中にセグメントの成長をさらに高めることができます。
頭蓋穿孔器の世界市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されます。このうち、欧州は、技術的に進歩した頭蓋穿孔器の増加、有利な償還政策、手術を必要とする疾患の有病率および発生率の上昇に起因して、世界全体で市場の顕著なシェアを占めると予想されます。
全地域の中で、北米が予測期間中に突出したシェアを占めると予測されています。市場成長の背景には、神経疾患の罹患率の上昇、手術技術の進歩、高齢者人口の増加、神経外科手術の継続的な研究開発などがあります。さらに、規制当局の承認、有利な償還政策、ヘルスケアインフラが市場拡大に大きく寄与しています。脳動脈瘤財団によると、米国では推定670万人が未破裂脳動脈瘤を患っており、これは50人に1人の割合です。破裂した脳動脈瘤は新たな脳卒中全体の3~5%を占める。この地域の先進的な医療研究環境は、医療機器メーカー、研究機関、ヘルスケアプロバイダー間の連携を促進しています。このようなパートナーシップは、個別化医療と患者に特化した機器に重点を置き、頭蓋穿孔器の技術革新を推進しています。
Title: Global Cranial Perforators Market Size, Share & Trends Analysis Report by Type (Reusable cranial perforators and Disposable cranial perforators), by End-User (Hospitals and Ambulatory Surgical Centers),Forecast Period (2023-2030).
The global cranial perforators market is anticipated to grow at a CAGR of 7.8% during the Forecast Period (2023-2030). The demand for cranial surgeries is steadily increasing owing to the rising prevalence of neurological disorders, including brain tumors, traumatic brain injuries, and intracerebral hemorrhages, which is projected to upsurge the demand for cranial perforators. According to the World Health Organization, around 50 million people have epilepsy, making it one of the most common neurological diseases globally.
The global cranial perforators market is segmented on the type, and end-user. Based on the type, the market is sub-segmented into reusable cranial perforators and disposable cranial perforators. Further, based on the end-user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the type, the disposable cranial perforators sub-segment is anticipated to hold a considerable share of the market, owing to the eliminating the risk of cross-contamination and infection transmission, saving valuable operating room time compared to reusable cranial perforators that require reprocessing.
Among the product, the hospitals sub-segment is expected to hold a considerable share of the global cranial perforators market. The hospitals segment accounted for the largest market share of 60.4% in 2022. This is due to the increasing hospitalization of patients with neurological disease conditions. According to the National Center for Biotechnology Information (NCBI), each year, 22.6 million people suffer from neurological injuries or disorders, of whom 13.8 million need surgery for their treatment. Thus, the increasing number of neurological hospital admission boost the demand for devices required for surgery, thereby driving segment growth. The availability of technologically advanced cranial perforators, coupled with favorable reimbursement policies, can further enhance segment growth during the forecast period.
The global cranial perforators market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing technologically advanced cranial perforators, coupled with favorable reimbursement policies, rising prevalence and incidence of diseases that require surgery.
Among all regions, North America is anticipated to hold a prominent share over the forecast period. The market growth is attributed to the rising incidence of neurological disorders, advancements in surgical techniques, the rising geriatric population, and continuous R&D in neurosurgical procedures. Moreover, regulatory approvals, favorable reimbursement policies, and healthcare infrastructure significantly contribute to the market's expansion. According to the Brain Aneurysm Foundation, an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Ruptured brain aneurysms account for 3-5% of all new strokes. The region's advanced medical research landscape fosters collaborations between medical device manufacturers, research institutions, and healthcare providers. These partnerships drive innovation in cranial perforators, with an emphasis on personalized medicine and patient-specific instruments.
The major companies serving the global cranial perforators market include: ACRA-CUT Inc., American Surgical Co., Integra LifeSciences Corp., Nouvag AG, adeor medical AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, adeor medical AG entered into partnership with IMEDCARE to exclusively distribute products in Australia through Imedcare.